Veracyte reported $3.13B in Market Capitalization this September of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Agenus USD 128M 21M Mar/2026
Agilent USD 39.08B 6.43B Jun/2026
Anika Therapeutics USD 139M 3M Dec/2025
Arrowhead Research USD 11.5B 2.72B Jun/2026
Bruker USD 9.16B 3.66B Jun/2026
Heron Therapeutics USD 238M 7M Dec/2025
Illumina USD 26.71B 8.84B Jun/2026
Karyopharm Therapeutics USD 126M 9M Mar/2026
Laboratory Of America USD 22.96B 1.03B Jun/2026
Ligand Pharmaceuticals USD 6.34B 2.35B Jun/2026
Roche Holding CHF 270B 3.66B Jun/2026
Siemens EUR 219.86B 59B Jun/2026
Thermo Fisher Scientific USD 190.65B 7.99B Jun/2026
Veracyte USD 4.69B 2.12B Jun/2026
Waters USD 37.24B 7.38B Jun/2026